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Each year about 140 new adult movement 
disorder patients, more men than 
women, are registered on the Exeter 
Movement Disorders Clinic Database 
(MDDB). 
Mean patient age at first 
hospital consultation is 70 
years for men and 71 for 
women, but there is a very 
wide range for both sexes. 
Most patients have 
had symptoms for 
about 5 years before 
first seeing a specialist,  
but some have been 
symptomatic for 
decades. 
Most movement disorders are 
chronic neurodegenerative 
disorders requiring regular 
specialist reassessment and 
adjustments to treatment over 
many years, so patients are 
followed-up for life. 
Long-term follow-up gives the opportunity for patients and their carers to participate in long-term trials.  
Although a 
wide range of 
disorders are 
seen, 70% of 
registered 
patients have 
idiopathic or 
probable 
Parkinson’s 
disease.  
Involvement with research from an early stage is vital if the more 
meaningful longer-term research questions are to be answered.  
A large randomised assessment 
of the relative cost-
effectiveness of different 
classes of drugs for Parkinson's 
disease 
A large, pragmatic, multicentre 
randomised controlled trial to 
assess the clinical and cost-
effectiveness of physiotherapy 
and occupational therapy in 
Parkinson's disease 
A national Parkinson's disease 
DNA bank 
Patient, carer and clinician engagement requires education 
about, and understanding of, longer-term goals in terms of 
patient quality of life whilst avoiding a ‘quick fix’ approach to 
treatment of chronic disorders. 
 
 
 
Successful long-term collaboration, over more than a decade, between Royal Devon and 
Exeter Hospital and Birmingham Clinical Trials Unit has enabled south-west patients and 
carers to make significant contributions to three of the largest ever Parkinson’s studies. 
Exeter has topped recruitment tables for PD MED and PD REHAB trials and PD GEN DNA 
bank. 
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